PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
N/A
New/Continuing Activity: New Activity
Continuing Activity:
Program Budget Code: 15 - HTXD ARV Drugs
Total Planned Funding for Program Budget Code: $0
Program Area Narrative:
Program Budget Code: 16 - HLAB Laboratory Infrastructure
Total Planned Funding for Program Budget Code: $69,500
UNAIDS estimates there are 270,000 Indonesians infected with the virus that causes HIV. The GOI currently reports offering ART
services at approximately 237 health facilities, including 124 hospitals and a limited number of Community Health Centers. The
MOH developed laboratory standards and guidelines and conducted national training sessions for lab technicians in each of the
237 health facilities. A recent round of monitoring visits to ART sites, jointly undertaken by the MOH, WHO, and the USG-
supported Aksi Stop AIDS (ASA) Program, implemented by FHI, suggests, however, that the number of sites actually providing
services is much smaller and is largely confined to the original 25 hospitals covered in the national scale-up scheme. The Minister
of Health has recently proposed a more rapid expansion of ART service sites, with a target of 482 facilities by the end of 2010.
However, resources needed to accomplish this have not yet been identified.
The MOH reports that 13,757 patients have ever received ARV at the end of April 2008, representing approximately 81% of the
official GOI estimate of those in need. Of these, 11,142 were males, 2,322 females, and 293 children under 14. The MOH reports
8,145 patients are currently receiving ART. The MOH projects expanding the number of individuals receiving ARV combination
therapy to 15,000 by March 2010; this increase will be supported with Global Fund monies. The number of military personnel
currently on ART is limited.
Currently, ARV drugs and CD4 tests are provided free-of-charge by the GOI, supported by GFATM. However, all other treatment
costs must be borne by patients. The MOH is responsible for supply chain management of ARV drugs. Although GFATM funding
appears to be sufficient, concerns continue to be voiced from the field on the reliability of supply. The current laboratory system is
weak though the GOI has set up a quality assurance system. The government financially supports an annual external quality
assurance assessment for 124 hospitals that provide ART, 50 blood transfusion units, and 30 health laboratories (26 provincial, 4
central). Unfortunately, a limited number of the total primary health care centers receive annual QA due to lack of supporting funds
from the GOI.
To date, the DOD funded portion of the USG program has provided laboratory equipment and supplies to two military referral
hospitals in Jakarta and two other military medical laboratories not located in Jakarta. At present, efforts in supporting laboratory
capacity include: AusAID support to one hospital, RS Sulianti Saroso, by supplying equipment and supplies to perform CD4 tests;
Global Fund support for CD4 machines and reagents for ART referral Hospitals; Clinton Foundation is supporting External Quality
Assessment (EQA) for CD4 testing, with the ultimate goal of establishing a National External Quality Assessment Service
(NEQAS) in Indonesia and is supporting scaling up treatment of pediatric HIV and will assist in developing a national infant
diagnosis system.
USG program focus will be placed on supporting laboratory capacity and expanding coverage of quality lab support services to
PLWHA through the Indonesia Defense Forces. DOD will continue collaboration with the TNI/PUSKES to improve and support
the laboratory capacity within the military laboratory facilities outside the capitol. In addition, critical HIV disposable supplies,
including reagents will be procured.
With FY09 funds, DOD will support a workshop to train military laboratory technicians from throughout the country and provide
necessary reagents for the three FACSCOUNT® CD4 machines previously procured with PEPFAR support. This activity will
increase the number of military medical facilities that will have trained laboratory staff as well as ensure a reliable supply of
reagents in support of those living with HIV/AIDS and seeking care at military facilities. Additionally, USG and implementing
partner staff have collaborated with the Directorate of Public Health Laboratories, the Department of Clinical Pathology of the
University of Indonesia, the HIV National Reference Laboratory at Cipto Mangunkusumo Hospital and the Balai Laboratorium
Kesehatan in Surabaya to develop appropriate external quality control systems for laboratory diagnosis of HIV and STIs. FY 2009
funds will also support technical assistance as required.
Table 3.3.16:
